These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32485570)

  • 21. SOX4-activated lncRNA MCM3AP-AS1 aggravates osteoarthritis progression by modulating miR-149-5p/Notch1 signaling.
    Xu F; Hu QF; Li J; Shi CJ; Luo JW; Tian WC; Pan LW
    Cytokine; 2022 Apr; 152():155805. PubMed ID: 35202986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-383-5p inhibits human malignant melanoma cells function via targeting CENPF.
    Xu H; Zhu X; Shi L; Lin N; Li X
    Reprod Biol; 2021 Sep; 21(3):100535. PubMed ID: 34274651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA MCM3AP-AS1 protects chondrocytes ATDC5 and CHON-001 from IL-1β-induced inflammation via regulating miR-138-5p/SIRT1.
    Shi J; Cao F; Chang Y; Xin C; Jiang X; Xu J; Lu S
    Bioengineered; 2021 Dec; 12(1):1445-1456. PubMed ID: 33942704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
    Fu A; Yu Z; Zhang E; Song J
    Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis.
    Fang J; Jiang G; Mao W; Huang L; Huang C; Wang S; Xue H; Ke J; Ni Q
    Bioengineered; 2022 Feb; 13(2):3707-3723. PubMed ID: 35094653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1.
    Wu Z; Liu Y; Wei L; Han M
    J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
    Zhao W; Geng D; Li S; Chen Z; Sun M
    Cancer Med; 2018 Mar; 7(3):842-855. PubMed ID: 29473328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA
    Zhang H; Luo C; Zhang G
    DNA Cell Biol; 2019 Aug; 38(8):857-864. PubMed ID: 31237446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
    Lan L; Liang Z; Zhao Y; Mo Y
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31985002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
    Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
    J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p.
    Zhou T; Lin K; Nie J; Pan B; He B; Pan Y; Sun H; Xu T; Wang S
    Pathol Res Pract; 2021 Jan; 217():153268. PubMed ID: 33246290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.